47 related articles for article (PubMed ID: 15210041)
1. Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance.
Zhou J; Lei N; Tian W; Guo R; Chen M; Qiu L; Wu F; Li Y; Chang L
Front Oncol; 2022; 12():999643. PubMed ID: 36313645
[TBL] [Abstract][Full Text] [Related]
2. Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
Esen I; Jiemy WF; van Sleen Y; Bijzet J; de Jong DM; Nienhuis PH; Slart RHJA; Heeringa P; Boots AMH; Brouwer E
Rheumatology (Oxford); 2022 Jul; 61(7):3060-3070. PubMed ID: 34730794
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2.
Meoli L; Gupta NK; Saeidi N; Panciotti CA; Biddinger SB; Corey KE; Stylopoulos N
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E613-E621. PubMed ID: 29462566
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma.
Liu Y; Wu H; Mei Y; Ding X; Yang X; Li C; Deng M; Gong J
Sci Rep; 2017 Nov; 7(1):15294. PubMed ID: 29127353
[TBL] [Abstract][Full Text] [Related]
5. A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.
Corbin Z; Spielman D; Recht L
Curr Oncol Rep; 2017 Nov; 19(12):84. PubMed ID: 29098465
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
7. Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.
Sanders E; Diehl S
Oncoscience; 2015; 2(2):151-86. PubMed ID: 25859558
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
[TBL] [Abstract][Full Text] [Related]
9. Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II.
Kolokythas A; Miloro M; Zhou X
J Oral Maxillofac Res; 2011 Jul; 2(2):e2. PubMed ID: 24421989
[TBL] [Abstract][Full Text] [Related]
10. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.
Tonus C; Sellinger M; Koss K; Neupert G
World J Gastroenterol; 2012 Aug; 18(30):4004-11. PubMed ID: 22912551
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.
Dhar DK; Olde Damink SW; Brindley JH; Godfrey A; Chapman MH; Sandanayake NS; Andreola F; Mazurek S; Hasan T; Malago M; Pereira SP
Cancer; 2013 Feb; 119(3):575-85. PubMed ID: 22864959
[TBL] [Abstract][Full Text] [Related]
12. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.
Meng W; Zhu HH; Xu ZF; Cai SR; Dong Q; Pan QR; Zheng S; Zhang SZ
World J Gastrointest Oncol; 2012 Jun; 4(6):145-51. PubMed ID: 22737276
[TBL] [Abstract][Full Text] [Related]
13. A study of PKM2, PFK-1, and ANT1 expressions in cervical biopsy tissues in China.
Yuan Y; Guo-Qing P; Yan T; Hong-Lin Y; Gong-Hua H; Cai-Gao Z
Med Oncol; 2012 Dec; 29(4):2904-10. PubMed ID: 22227854
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma.
Peng XC; Gong FM; Zhao YW; Zhou LX; Xie YW; Liao HL; Lin HJ; Li ZY; Tang MH; Tong AP
PLoS One; 2011; 6(11):e27309. PubMed ID: 22087286
[TBL] [Abstract][Full Text] [Related]
15. [ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients].
ZHANG Y; LI M; LIU Y; HAN N; ZHANG K; XIAO T; CHENG S; GAO Y
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1089-93. PubMed ID: 21159241
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang.
Liu Z; Feng JG; Tuersun A; Liu T; Liu H; Liu Q; Zheng ST; Huang CG; Lv GD; Sheyhidin I; Lu XM
Mol Biol Rep; 2011 Jun; 38(5):3261-9. PubMed ID: 21125333
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.
Du XL; Hu H; Lin DC; Xia SH; Shen XM; Zhang Y; Luo ML; Feng YB; Cai Y; Xu X; Han YL; Zhan QM; Wang MR
J Mol Med (Berl); 2007 Aug; 85(8):863-75. PubMed ID: 17318615
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.
Tonus C; Neupert G; Sellinger M
World J Gastroenterol; 2006 Nov; 12(43):7007-11. PubMed ID: 17109496
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma.
Kaura B; Bagga R; Patel FD
J Obstet Gynaecol Res; 2004 Jun; 30(3):193-6. PubMed ID: 15210041
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
